Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 1/20 | 0.52 |
| ▸ | ICMT | O60725 | 1/20 | 0.51 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.48 |
| ▸ | CDK9 | P50750 | 2/20 | 0.48 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.48 |
| ▸ | CDK2 | P24941 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 8/20 | 0.47 |
| ▸ | CNR1 | P21554 | 3/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | DNM2 | P50570 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10967590 | 0.86 | CDC25A (0.66) | CDC25AICMTCNR2CNR1DNM2 | |
| SCHEMBL8126918 | 0.78 | CDC25A (0.64) | CDC25AICMTCNR2CNR1DNM2 | |
| SCHEMBL3886988 | 0.77 | ICMT (0.64) | CDC25AICMTCNR2CNR1DNM2 | |
| SCHEMBL13131369 | 0.76 | CDC25A (0.72) | CDC25AICMTCNR2CNR1DNM2 | |
| SCHEMBL22411431 | 0.76 | ICMT (0.66) | CDC25AICMTCNR2CNR1DNM2 | |
| SCHEMBL5462804 | 0.75 | CDC25A (0.70) | CDC25AICMTCNR2CNR1DNM2 | |
| SCHEMBL17943470 | 0.74 | CDC25A (0.57) | CDC25AICMTCNR2DNM2 | |
| SCHEMBL3449953 | 0.74 | POLB (0.63) | CDC25AICMTCNR2CNR1DNM2 | |
| SCHEMBL5154476 | 0.74 | CCNT1 (0.48) | CDC25AICMTCCNT1CDK9CCNA2 | |
| SCHEMBL17464416 | 0.74 | CNR2 (0.61) | CDC25AICMTCNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115884761-A | Transdermal pharmaceutical formulations of cannabinoids | 长矛治疗股份有限公司 | 2023-03-31 | — | — | CN | disclosed |